Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAmerican Oncology Network, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.19 | $470.28 M | |||
| 08/14/2024 | Q2 2024 | $0.12 | $433.98 M | |||
| 03/30/2024 | Q1 2024 | -$1.22 | $364.34 M | |||
| 12/30/2023 | Q4 2023 | -$0.56 | $324.18 M | |||
| 09/29/2023 | Q3 2023 | -$0.61 | $336.31 M | |||
| 06/28/2023 | Q2 2023 | -$0.17 | $314.97 M | |||
| 05/12/2023 | Q1 2023 | $0.01 | $303.73 M | |||
| 12/30/2022 | Q4 2022 | $0.27 | $300.40 M | |||
| 09/29/2022 | Q3 2022 | $0.36 | $297.32 M | |||
| 08/12/2022 | Q2 2022 | $0.04 | $0 | |||
| 05/17/2022 | Q1 2022 | $0.08 | $0 | |||
| 04/13/2022 | Q4 2021 | -$0.01 | $0 | |||
| 11/19/2021 | Q3 2021 | $0.08 | $0 | |||
| 08/24/2021 | Q2 2021 | $0.20 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.01 | $0 |
American Oncology Network, Inc. Earnings: FAQ's
How can I listen to American Oncology Network, Inc.'s earnings conference
call?
The conference call for American Oncology Network, Inc.'s latest earnings report can be listened to online.
How can I read American Oncology Network, Inc.'s conference call transcript?
The conference call transcript for American Oncology Network, Inc.'s latest earnings report can be read online.
How much revenue does American Oncology Network, Inc. generate each year?
American Oncology Network, Inc. (:AONC) has a recorded annual revenue of $1.28 B.
How much profit does American Oncology Network, Inc. generate each year?
American Oncology Network, Inc. (:AONC) has a recorded net income of $1.28 B. American Oncology Network, Inc. has generated $-1.36 earnings per share over the last four quarters.
What is American Oncology Network, Inc.'s price-to-earnings ratio?
American Oncology Network, Inc. (:AONC) has a price-to-earnings ratio of -6.34 and price/earnings-to-growth ratio is -0.34.